{"title":"贝伐单抗治疗非鳞癌非小细胞肺癌患者的脑放射坏死","authors":"","doi":"10.1016/j.cllc.2024.06.010","DOIUrl":null,"url":null,"abstract":"<div><p></p><ul><li><span>•</span><span><p>The incidence of brain radiation necrosis is increasing in NSCLC patients undergoing radiotherapy for brain metastases.</p></span></li><li><span>•</span><span><p>[<sup>11</sup>C] methionine–PET and MRS are valuable tools for diagnosing brain radiation necrosis.</p></span></li><li><span>•</span><span><p>Bevacizumab is an effective treatment for brain radiation necrosis in patients with nonsquamous NSCLC.</p></span></li></ul></div>","PeriodicalId":10490,"journal":{"name":"Clinical lung cancer","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1525730424001359/pdfft?md5=6792b8d4e751aaccaf770a85083f2252&pid=1-s2.0-S1525730424001359-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Bevacizumab for Brain Radiation Necrosis in Patients With Nonsquamous Nonsmall Cell Lung Cancer\",\"authors\":\"\",\"doi\":\"10.1016/j.cllc.2024.06.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p></p><ul><li><span>•</span><span><p>The incidence of brain radiation necrosis is increasing in NSCLC patients undergoing radiotherapy for brain metastases.</p></span></li><li><span>•</span><span><p>[<sup>11</sup>C] methionine–PET and MRS are valuable tools for diagnosing brain radiation necrosis.</p></span></li><li><span>•</span><span><p>Bevacizumab is an effective treatment for brain radiation necrosis in patients with nonsquamous NSCLC.</p></span></li></ul></div>\",\"PeriodicalId\":10490,\"journal\":{\"name\":\"Clinical lung cancer\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2024-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1525730424001359/pdfft?md5=6792b8d4e751aaccaf770a85083f2252&pid=1-s2.0-S1525730424001359-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical lung cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1525730424001359\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical lung cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1525730424001359","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.